Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Enobia's ENB-0040 receives FDA fast track designation

May 22, 2009

Copper/AAV-based gene therapy increases survival in model of Menkes disease / News in Context

May 22, 2009

Mipomersen study meets endpoints in homozygous familial hypercholesterolemia

May 21, 2009

Merck KGaA discovers SGLT inhibitors for the treatment of diabetes

May 21, 2009

Biopure presents an update on the NMRC's clinical development of Hemopure

May 21, 2009

Merck Serono withdraws offer for reproductive technology company MediCult

May 21, 2009

Neurocrine reports results from Petal Study of elagolix for endometriosis pain

May 20, 2009

FDA accepts for filing MannKind's NDA for insulin product Afresa

May 20, 2009

Phase IIb DCCR trial for hypertriglyceridemia meets endpoint

May 19, 2009

Studies reveal contraceptive efficacy of estradiol valerate/dienogest

May 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....